The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts

References

• Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005 Feb;26(2):166–74.10.1086/502522
   PubMed Web of Science ®Google Scholar
• Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. J Clin Microbiol. 2011 Jan;49(1):269–74.10.1128/JCM.00914-10
   PubMed Web of Science ®Google Scholar
• Gould IM. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents. 2008 Apr;31(Suppl 2):1–9.10.1016/S0924-8579(08)70002-5
   PubMedGoogle Scholar
• Diaz R, Ramalheira E, Afreixo V, Gago B. Evaluation of vancomycin MIC creep in Staphylococcus aureus. J Glob Antimicrob Resist. 2017 Sep;10:281–284.10.1016/j.jgar.2017.04.007
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clini Inf Dis. 2011 Feb 1;52(3):e18–55.10.1093/cid/ciq146
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation. 2015 Oct 13;132(15):1435–86. Erratum in: Circulation. 2016 Aug 23;134(8):e113.10.1161/CIR.0000000000000296
   PubMed Web of Science ®Google Scholar
• Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Inf Dis. 2013 Jan;56(1):e1–25.10.1093/cid/cis803
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075–128.10.1093/eurheartj/ehv319
   PubMed Web of Science ®Google Scholar
• Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND Corporation; 2001 [cited 2017 Oct]. Available from: www.rand.org/pubs/monograph_reports/MR1269.html
   Google Scholar
• Byrne CJ, Egan S, Fennell JP, O’Byrne P, Enright H, Deasy E, et al. Teicoplanin use in adult patients with haematological malignancy: exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity. Int J Antimicrob Agents. 2015 Oct;46(4):406–12.10.1016/j.ijantimicag.2015.05.019
   PubMed Web of Science ®Google Scholar
• Matthews PC, Chue AL, Wyllie D, Barnett A, Isinkaye T, Jefferies L, et al. Increased teicoplanin doses are associated with improved serum levels but not drug toxicity. J Infect. 2014 Jan;68(1):43–9.10.1016/j.jinf.2013.08.018
   PubMed Web of Science ®Google Scholar
• Álvarez O, Plaza-Plaza JC, Ramirez M, Peralta A, Amador CA, Amador R. Pharmacokinetic assessment of vancomycin loading dose in critically ill patients. Antimicrob Agents Chemother. 2017 Jul 25;61(8).
   Web of Science ®Google Scholar
• Pea F, Viale P. Should the currently recommended twice daily dosage of vancomycin still be considered appropriate for treatment of MRSA ventilator associated pneumonia? Clin Pharmacokinetics. 2008;47(3):147–52.10.2165/00003088-200847030-00001
   PubMed Web of Science ®Google Scholar
• Blot S. MRSA pneumonia: better outcome through continuous infusion of vancomycin? Crit Care Med. 2005 Sep;33(9):2127–8.10.1097/01.CCM.0000178288.70057.47
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Inf Dis. 2007;44(Suppl 2):S27–72.10.1086/511159
   PubMed Web of Science ®Google Scholar
• Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014 Sep;58(9):5262–8.10.1128/AAC.02582-14
   PubMed Web of Science ®Google Scholar
• Falcone M, Russo A, Giannella M, Cangemi R, Scarpellini MG, Bertazzoni G, et al. Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS ONE. 2015 Apr 10;10(4):e0119528.10.1371/journal.pone.0119528
   PubMed Web of Science ®Google Scholar
• Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014 Sep;58(9):5262–8.see 10.1128/AAC.02582-14
   PubMed Web of Science ®Google Scholar
• Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo MI. Multidrug-resistant pathogens in patients with pneumonia coming from the community. Curr Opin Pulm Med. 2016 May;22(3):219–26.10.1097/MCP.0000000000000263
   PubMed Web of Science ®Google Scholar
• Di Pasquale M, Aliberti S, Mantero M, Bianchini S, Blasi F. Non-intensive care unit acquired pneumonia: a new clinical entity? Int J Mol Sci. 2016 Feb 25;17(3):287.10.3390/ijms17030287
   PubMed Web of Science ®Google Scholar
• Doudoulakakis AG, Bouras D, Drougka E, Kazantzi M, Michos A, Charisiadou A, et al. Community-associated Staphylococcus aureus pneumonia among Greek children: epidemiology, molecular characteristics, treatment, and outcome. Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1177–85.10.1007/s10096-016-2651-7
   PubMed Web of Science ®Google Scholar
• Borgatta B, Rello J. How to approach and treat VAP in ICU patients. BMC Infect Dis. 2014 Apr 30;14:211.10.1186/1471-2334-14-211
   PubMed Web of Science ®Google Scholar
• Claeys KC, Lagnf AM, Hallesy JA, Compton MT, Gravelin AL, Davis SL, et al. Pneumonia caused by methicillin-resistant Staphylococcus aureus: does vancomycin heteroresistance matter? Antimicrob Agents Chemother. 2016 Jan 4;60(3):1708–16.10.1128/AAC.02388-15
   PubMed Web of Science ®Google Scholar
• Chastre J, Blasi F, Masterton RG, Relio J, Torres A, Welte T. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect. 2014 Apr;20(Suppl 4):19–36.10.1111/1469-0691.12450
   PubMedGoogle Scholar
• Farrell DJ, Flamm RK, Sader HS, Jones RN. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types. Int J Antimicrob Agents. 2014 Apr;43(4):323–7.10.1016/j.ijantimicag.2013.11.005
   PubMed Web of Science ®Google Scholar
• Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Inf Dis. 2001 Feb 1;32(3):402–12.10.1086/318486
   PubMed Web of Science ®Google Scholar
• Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev. 2014 Oct;27(4):647–64.10.1128/CMR.00002-14
   PubMed Web of Science ®Google Scholar
• Esposito S, Terranova L, Zampiero A, Ierardi V, Rios WP, Pelucchi C, et al. Oropharyngeal and nasal Staphylococcus aureus carriage by healthy children. BMC Infect Dis. 2014 Dec 31;14:723.10.1186/s12879-014-0723-9
   PubMed Web of Science ®Google Scholar
• Esposito S, Terranova L, Ruggiero L, Ascolese B, Montinaro V, Rios WP, et al. Streptococcus pneumoniae and Staphylococcus aureus carriage in healthy school-age children and adolescents. J Med Microbiol. 2015 Apr;64(Pt 4):427–31.10.1099/jmm.0.000029
   PubMedGoogle Scholar
• Pan A, Lee A, Cooper B, Chalfine A, Daikos GL, Garilli S, et al. Risk factors for previously unknown meticillin-resistant Staphylococcus aureus carriage on admission to 13 surgical wards in Europe. J Hosp Infect. 2013 Feb;83(2):107–13.10.1016/j.jhin.2012.09.020
   PubMed Web of Science ®Google Scholar
• Gasch O, Ayats J, Ángeles Dominguez M, Tubau F, Liñares J, Peña C, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital. Medicine. 2011 Sep;90(5):319–27.10.1097/MD.0b013e31822f0b54
   PubMed Web of Science ®Google Scholar
• Brink AJ. Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the ‘creeps’? Curr Opin Crit Care. 2012 Oct;18(5):451–9.10.1097/MCC.0b013e3283578968
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Inf Dis. 2012 Mar;54(6):755–71.10.1093/cid/cir935
   PubMed Web of Science ®Google Scholar
• Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014 Oct 1;312(13):1330–1341.10.1001/jama.2014.9743
   PubMed Web of Science ®Google Scholar
• Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Inf Dis. 2012 Jan 1;54(1):51–8.10.1093/cid/cir764
   PubMed Web of Science ®Google Scholar
• Cojutti P, Scarparo C, Sartor A, Coato P, Rigoli R, Pea F. A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy. Diagn Microbiol Infect Dis. 2015 Jan;81(1):53–6.10.1016/j.diagmicrobio.2014.09.016
   PubMed Web of Science ®Google Scholar
• Pea F, Lugano M, Baccarani U, Della Rocca G, Viale P. Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. J Antimicrob Chemother. 2014 Feb;69(2):567–8.10.1093/jac/dkt382
   PubMed Web of Science ®Google Scholar
• Pea F, Viale P, Pavan F, Tavio M, Poz D, Beltrame A, et al. The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin. Int J Antimicrob Agents. 2006 Apr;27(4):344–50.10.1016/j.ijantimicag.2005.11.012
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yokoyama Y, et al. Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections. Clin Pharmacol. 2016 Mar;30(8):15–18.
   Google Scholar
• Kato H, Hamada Y, Hagihara M, Hirai J, Nishiyama N, Koizumi Y, et al. Retrospective study of teicoplanin loading regimen that rapidly achieves target 15–30 μg/mL serum trough concentration. J Infect Chemother. 2016 May;22(5):308–13.10.1016/j.jiac.2016.01.019
   PubMed Web of Science ®Google Scholar
• Yoon YK, Park DW, Sohn JW, Kim HY, Kim YS, Lee CS, et al. Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2014;58(1):317–24.10.1128/AAC.00520-13
   PubMed Web of Science ®Google Scholar
• Ortiz-Bautista C, López J, García-Granja PE, Sevilla T, Vilacosta I, Sarriá C, et al. Current profile of infective endocarditis in intravenous drug users: the prognostic relevance of the valves involved. Int J Cardiol. 2015;187:472–4.10.1016/j.ijcard.2015.03.368
   PubMed Web of Science ®Google Scholar
• Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian study on endocarditis. Infection. 2012 Oct;40(5):527–35.10.1007/s15010-012-0285-y
   PubMed Web of Science ®Google Scholar
• Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med. 2012 Feb 27;172(4):363–5.10.1001/archinternmed.2011.1027
   PubMedGoogle Scholar
• Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005 Jun 22;293(24):3012–21.10.1001/jama.293.24.3012
   PubMed Web of Science ®Google Scholar
• Martí-Carvajal AJ, Dayer M, Conterno LO, Gonzalez Garay AG, Martí-Amarista CE, Simancas-Racines D. A comparison of different antibiotic regimens for the treatment of infective endocarditis. Cochrane Database Syst Rev. 2016 Apr;19(4):CD009880.
   Google Scholar
• Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, et al. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2014 Aug;58(8):4636–41.10.1128/AAC.02820-13
   PubMed Web of Science ®Google Scholar
• Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006 Aug 17;355(7):653–65.10.1056/NEJMoa053783
   PubMed Web of Science ®Google Scholar
• Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, et al. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):625–31.10.1007/s10096-016-2581-4
   PubMed Web of Science ®Google Scholar
• Stefani S, Campanile F, Santagati M, Mezzatesta ML, Cafiso V, Pacini G. Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: a review of the available evidence. Int J Antimicrob Agents. 2015 Sep;46(3):278–89.10.1016/j.ijantimicag.2015.05.008
   PubMed Web of Science ®Google Scholar
• Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, Nizet V, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Inf Dis. 2011 Jul 15;53(2):158–63.10.1093/cid/cir340
   PubMed Web of Science ®Google Scholar
• Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ. Evaluation of ceftaroline alone and in combination against biofilm-producing methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin and vancomycin in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2015 Aug;59(8):4497–503.10.1128/AAC.00386-15
   PubMed Web of Science ®Google Scholar
• Chambers HF, Basuino L, Hamilton SM, Choo EJ, Moise P. Daptomycin-β-lactam combinations in a rabbit model of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 2016 Jun 20;60(7):3976–9.10.1128/AAC.00589-16
   PubMed Web of Science ®Google Scholar
• Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet. 2016 Jan 23;387(10016):386–94.10.1016/S0140-6736(14)61798-0
   PubMed Web of Science ®Google Scholar
• Campanile F, Bongiorno D, Borbone S, Stefani S. Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy. Ann Clin Microbiol Antimicrob. 2009 Jun 24;8:22.10.1186/1476-0711-8-22
   PubMed Web of Science ®Google Scholar
• Niska JA, Shahbazian JH, Ramos RI, Francis KP, Bernthal NM, Miller LS. Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection. Antimicrob Agents Chemother. 2013 Oct;57(10):5080–6.10.1128/AAC.00702-13
   PubMed Web of Science ®Google Scholar
• Tascini C, Tagliaferri E, Di Paolo A, Ciofi L, Del Tacca M, Lambelet P, et al. Three-times weekly teicoplanin as outpatient treatment of chronic osteoarticular infections. J Chemother. 2009 Aug;21(4):421–5.10.1179/joc.2009.21.4.421
   PubMed Web of Science ®Google Scholar
• Allen J, Adams K, Thompson F, Cullen L, Barlow G. Long-term, once-weekly outpatient teicoplanin use for suppression of chronic prosthetic joint infection. Int J Antimicrob Agents. 2013 Feb;41(2):200–1.10.1016/j.ijantimicag.2012.10.006
   PubMed Web of Science ®Google Scholar
• Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, et al. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008 Sep;52(9):3315–20.10.1128/AAC.00113-08
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Inf Dis. 2014 Jul 15;59(2):e10–e52. Erratum in Clin Infect Dis 2014; 59:147-59.10.1093/cid/ciu296
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra‐abdominal infection in adults and children: guidelines by the surgical infection society and the Infectious Diseases Society of America. Clin Inf Dis. 2010 Jan 15;50(2):133–64. Erratum in Clin Infect Dis. 2010 Jun 15;50(12):1695.10.1086/648977
   PubMed Web of Science ®Google Scholar
• Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013 Jan 8;8(1):3.10.1186/1749-7922-8-3
   PubMedGoogle Scholar
• Jannasch O, Kelch B, Adolf D, Tammer I, Lodes U, Weiss G, et al. Nosocomial infections and microbiologic spectrum after major elective surgery of the pancreas, liver, stomach, and esophagus. Surg Infect (Larchmt). 2015 Jun;16(3):338–45.10.1089/sur.2013.248
   PubMed Web of Science ®Google Scholar
• Kurup A, Liau KH, Ren J, Lu MC, Navarro NS, Farooka MW, et al. Antibiotic management of complicated intra-abdominal infections in adults: the Asian perspective. Ann Med Surg (Lond). 2014 Aug 7;3(3):85–91.10.1016/j.amsu.2014.06.005
   PubMedGoogle Scholar
• Kitterer D, Latus J, Pöhlmann C, Alscher MD, Kimmel M. Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in GERMANY over 32 years. PLoS ONE. 2015;10(9):e0135969.10.1371/journal.pone.0135969
   PubMed Web of Science ®Google Scholar
• Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, et al. Acute bacterial meningitis in adults – a review of 493 episodes. N Engl J Med. 1993 Jan 7;328(1):21–8.10.1056/NEJM199301073280104
   PubMed Web of Science ®Google Scholar
• Hussein AS, Shafran SD. Acute bacterial meningitis in adults: a 12-year review. Medicine. 2000 Nov;79(6):360–8.10.1097/00005792-200011000-00002
   PubMed Web of Science ®Google Scholar
• Srinivas D, Veena Kumari HB, Somanna S, Bhagavatula I, Anandappa CB. The incidence of postoperative meningitis in neurosurgery: an institutional experience. Neurol India. 2011 Mar–Apr;59(2):195–8.10.4103/0028-3886.79136
   PubMed Web of Science ®Google Scholar
• Kumari VH, Babu AR, Srinivas D, Siddaiah N, Somanna S. Methicillin-resistant Staphylococcus aureus central nervous system infections-analysis and outcome. British Journal of Neurosurgery. 2015 Jun;29(3):413–8.10.3109/02688697.2015.1006168
   PubMed Web of Science ®Google Scholar
• Jorgenson L, Reiter PD, Freeman JE, Winston KR, Fish D, McBride LA, et al. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices. Pediatric Neurosurgery. 2007;43(6):449–55.10.1159/000108786
   PubMed Web of Science ®Google Scholar
• Wang Q, Shi Z, Wang J, Shi G, Wang S, Zhou J. Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients. Surgical Neurology. 2008 Feb;69(2):126–9.10.1016/j.surneu.2007.01.073
   PubMedGoogle Scholar
• Myrianthefs P, Markantonis SL, Vlachos K, Anagnostaki M, Boutzouka E, Panidis D, et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother. 2006 Dec;50(12):3971–6.10.1128/AAC.00051-06
   PubMed Web of Science ®Google Scholar
• Beer R, Engelhardt KW, Pfausler B, Broessner G, Helbok R, Lackner P, et al. Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother. 2007 Jan;51(1):379–82.10.1128/AAC.00515-06
   PubMed Web of Science ®Google Scholar
• Dudley MN, Levitz RE, Quintiliani R, Hickingbotham JM, Nightingale CH. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. Antimicrob Agents Chemother. 1984 Dec;26(6):811–4.10.1128/AAC.26.6.811
   PubMed Web of Science ®Google Scholar
• Nau R, Prange HW, Menck S, Kolenda H, Visser K, Seydel JK. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges. J Antimicrob Chemother. 1992 Jun;29(6):719–24.10.1093/jac/29.6.719
   PubMed Web of Science ®Google Scholar
• Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother. 2006 Apr;57(4):720–3.10.1093/jac/dkl007
   PubMed Web of Science ®Google Scholar
• Pfausler B, Spiss H, Beer R, Kampfl A, Engelhardt K, Schober M, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg. 2003 May;98(5):1040–4.10.3171/jns.2003.98.5.1040
   PubMed Web of Science ®Google Scholar
• Amod F, Moodley I, Peer AK, Sunderland J, Lovering A, Wootton M, et al. Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin. J Infect. 2005 Apr;50(3):252–7.10.1016/j.jinf.2004.04.002
   PubMed Web of Science ®Google Scholar
• Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Inf Dis. 2012 Jun;54(12):e132–73.10.1093/cid/cis346
   PubMed Web of Science ®Google Scholar
• Crouzet J, Lavigne JP, Richard JL, Sotto A, Nîmes University hospital working group on the diabetic foot (GP30). Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy. Int J Infect Dis. 2011;15:e601–e610.10.1016/j.ijid.2011.05.003
   PubMed Web of Science ®Google Scholar
• Peters EJ, Lipsky BA, Aragón-Sánchez J, Boyko EJ, Diggle M, Embil JM, et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32(Suppl 1):145–153.10.1002/dmrr.v32.S1
   PubMed Web of Science ®Google Scholar
• Lamont E, Seaton RA, Macpherson M, Semple L, Bell E, Thomson AH. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme. J Antimicrob Chemother. 2009;64(1):81–187.
   Web of Science ®Google Scholar